Price To Earnings Ratio 18.44 | Sector PE 71.67 |
PB Ratio 4.37 | Sector PB 9.22 |
EPS 77.56 | Dividend Yield 1.00 |
Today's Volume 597.750 K | 5 Day Avg. Volume 1.048 M |
PEG Ratio 0.19 | Market Cap. ₹ 24,640.00 Cr. |
Time | NATCOPHARM | VS | Industry |
---|---|---|---|
1 Day | 1.13% | -1.57% | |
1 Week | 5.85% | -0.71% | |
1 Month | 1.61% | -0.67% | |
6 Months | 34.81% | 19.22% | |
1 Year | 90.47% | 40.41% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 1372.35 | Bullish |
20 | 1365.49 | Bullish |
30 | 1363.27 | Bullish |
50 | 1367.76 | Bullish |
100 | 1414.04 | Bullish |
200 | 1252.8 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 1211.60 | 849.10 | 46.50 | 298.80 | |||||
Investing Activities | -1032.70 | -477.10 | -5.30 | -103.30 | |||||
Financing Activities | -246.90 | -363.00 | 34.80 | -185.70 | |||||
Net Cash Flow | -68.00 | 9.00 | 76.00 | 9.80 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
NATCO Pharma | 1.13 | 5.85 | 1.61 | 34.81 | 90.47 |
Alembic | -1.43 | 3.5 | 0.72 | 1.94 | 1.94 |
Aurobindo Pharma | 1.01 | -0.96 | -10.44 | -11.19 | 13.77 |
Fortis Healthcare | 3.83 | 8.97 | 18.47 | 48.89 | 80.61 |
Ajanta Pharmaceuticals | -1.16 | -5.34 | -8.54 | 12.68 | 38.9 |
Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.